B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nmn

An enzyme that catalyzes the formation of nicotinamide mononucleotide (NMN) from nicotinamide and 5-phosphoribosyl-1-pyrophosphate, the rate-limiting step in the biosynthesis of the NAD coenzyme. It is also known as a growth factor for early B-LYMPHOCYTES, or an ADIPOKINE with insulin-mimetic effects (visfatin).

300 PubMed studies analyzed · 5 RCTs · Evidence Score: 43.8

Research Domains

Nmn has been studied across 25 research domains including ⏳ Longevity & Aging, 🔬 Inflammation, 🧘 Stress & Anxiety, 🔥 Metabolic, ⚡ Energy & Fatigue. The primary research focus is ⏳ Longevity & Aging with 31% of studies addressing this area.

Loading evidence profile...

This evidence profile for Nmn is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.